| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/1062936X.2017.1404490 |
| P698 | PubMed publication ID | 29206501 |
| P50 | author | Serap Yilmaz | Q83848288 |
| P2093 | author name string | S Okten | |
| I Yalcin | |||
| E Aki-Yalcin | |||
| F K Onurdag | |||
| P2860 | cites work | Structural basis of gate-DNA breakage and resealing by type II topoisomerases | Q27324504 |
| Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases | Q27655501 | ||
| A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases | Q27661756 | ||
| Type IIA topoisomerase inhibition by a new class of antibacterial agents | Q27663884 | ||
| Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance | Q27664216 | ||
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins | Q32030823 | ||
| Mechanism of fluoroquinolone action | Q33745208 | ||
| GHKL, an emergent ATPase/kinase superfamily | Q33818817 | ||
| Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 | ||
| Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV. | Q35040946 | ||
| Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii | Q35114895 | ||
| Energy coupling in type II topoisomerases: why do they hydrolyze ATP? | Q36854054 | ||
| Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii | Q37156234 | ||
| From keys to bulldozers: expanding roles for winged helix domains in nucleic-acid-binding proteins. | Q38114607 | ||
| Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases. | Q38162903 | ||
| Designing type II topoisomerase inhibitors: A molecular modeling approach | Q38162907 | ||
| Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase | Q38255773 | ||
| Pharmacophore generation of 2-substituted benzothiazoles as AdeABC efflux pump inhibitors in A. baumannii. | Q43451889 | ||
| Nucleotide binding to DNA gyrase causes loss of DNA wrap | Q44799104 | ||
| Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors. | Q51063365 | ||
| Synthesis, antimicrobial activity and QSARs of new benzoxazine-3-ones. | Q51932899 | ||
| Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli. | Q53809684 | ||
| Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking. | Q53923658 | ||
| Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors. | Q54590811 | ||
| P433 | issue | 11 | |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 941-956 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | SAR and QSAR in Environmental Research | Q15724562 |
| P1476 | title | Synthesis and investigation of binding interactions of 1,4-benzoxazine derivatives on topoisomerase IV in Acinetobacter baumannii | |
| P478 | volume | 28 |
Search more.